Objective: Alternative activation (M2) of adipose tissue resident macrophage (ATM) inhibits obesity-induced metabolic inflammation. The underlying mechanisms remain unclear. Recent studies have shown that dysregulated lipid homeostasis caused by increased lipolysis in white adipose tissue (WAT) in the obese state is a trigger of inflammatory responses. We investigated the role of M2 macrophages in lipotoxicityinduced inflammation. Methods: We used microarray experiments to profile macrophage gene expression regulated by two M2 inducers, interleukin-4 (Il-4), and peroxisome proliferator-activated receptor delta/gamma (Ppard/Pparg) agonists. Functional validation studies were performed in bone marrowderived macrophages and mice deprived of the signal transducer and activator of transcription 6 gene (Stat6; downstream effector of Il-4) or Conclusions: Our data suggest that ATM cell death is closely linked to metabolic inflammation. Within WAT where concentrations of free fatty acids fluctuate, M2 polarization regulated by the Stat6-Ppar axis enhances ATM's tolerance to lipid-mediated stress, thereby maintaining the homeostatic state.
INTRODUCTION
Obesity and related metabolic syndrome are major medical and economic burdens worldwide. Chronic low-grade inflammation is often observed in obesity and is a key contributor to associated pathologies such as insulin resistance, type 2 diabetes, and atherosclerosis [1e3] . White adipose tissue (WAT) is a primary energy storing tissue that has been recognized as an important endocrine organ modulating metabolic-related inflammation (or meta-inflammation) through crosstalk with resident immune cells, such as macrophages and lymphocytes. In lean individuals, adipose tissue macrophages (ATMs) have an alternatively activated (M2) phenotype that limits inflammation and sustains homeostasis [1, 3] . With the onset of obesity, classically activated M1 macrophages preferentially accumulate in WAT and exhibit a pro-inflammatory phenotype characterized by the production of cytokines such as interleukin-1b (Il-1b) and tumor necrosis factor-a (Tnf-a) [1e3] . These M1 derived pro-inflammatory mediators have been shown to cause metabolic dysregulation and insulin resistance [1e3] . While this M1/M2 paradigm is instrumental for describing immune phenotypes in physiological and pathological states, recent studies have implicated a dynamic and complex ATM polarization process [4] . In addition, it has been shown that metabolically activated macrophages driven primarily by free fatty acids (FA) do not express M1 surface markers, despite increased production of Il-1b and Tnf-a in these cells [5] . Several stimuli from the adipose microenvironment have been reported to regulate the ATM phenotype. It has been suggested that at the lean state, eosinophils and type 2 innate lymphoid cells (ILC2s) constitutively produce Th2 cytokines interleukin-4 (Il-4) and interleukin-13 (Il-13), respectively, which promote M2 polarization [6, 7] . In the pathological context of obesity, adipocyte hypertrophy and cell death increase the production of chemokines, such as C-X-C motif chemokine ligand 12 (Cxcl12) and monocyte chemotactic protein-1 (Mcp-1) to recruit Ly6C hi Ccr2 þ monocytes into WAT [8, 9] , where CD8 þ cytotoxic T cells have been found to secrete interferon-g (Ifn-g) that contributes to macrophage M1 polarization [3, 10, 11] . In addition to the classical M1 activation, dysregulated lipid homeostasis caused by increased lipolysis in WAT has also been shown to be a trigger of inflammatory responses in ATMs as described above. Recent studies have demonstrated that saturated FA and their metabolites, notably ceramides, can act on NLR family pyrin domain containing 3 (Nlrp3) inflammasome formation, resulting in autocatalytic activation of caspase-1 and production of mature Il-1b to promote inflammation [12, 13] . Interestingly, WAT lipolysis by fasting or b-adrenergic stimulation can also drive ATM accumulation in lean individuals [14] . This raises the question of how M2 ATMs regulate FA-induced immune responses. Macrophage M2 polarization requires activation and cooperation of several transcriptional factors [3, 15] . Signal transducer and activator of transcription 6 (Stat6), the canonical effector of Th2 signaling, has been proposed to regulate mitochondrial oxidative metabolism to fuel M2 activation [3, 15, 16] . In mice, Stat6 controls the expression of nuclear receptors peroxisome proliferator-activated receptor delta (Ppard or Pparb) and gamma (Pparg), both of which can further modulate the function of M2 macrophages [9, 17, 18] . Ppard/Pparg are well-known lipid sensing nuclear receptors. A variety of endogenous lipids, including unsaturated FAs, saturated FAs and hydroxyeicosatetraenoic acids can physically bind to Ppard and Pparg, which, in turn, activate the transcriptional programs for FA oxidation, mitochondrial biogenesis, and anti-inflammatory response in macrophages [15, 19] . Stat6 À/À , myeloid-Ppard À/À , and myeloid-Pparg À/À mice are more prone to high fat diet induced WAT inflammation and insulin resistance [17,20e22] . The metabolic function of the Stat6-Ppar signaling cascade implicates a role for M2 macrophages in mediating FA homeostasis within WAT. The current study aims to identify potential physiological functions of M2 polarization in ATMs. Through expression profiling and genetic approaches, we find that the Stat6-Ppar axis plays an important role in protecting macrophages against lipotoxicityinduced cellular dysfunction. This is mediated by transcriptional regulation of cell death/pro-survival genes, in addition to their known function in FA metabolism and mitochondrial respiration. Dysregulation of M2 signaling, such as in Stat6 À/À and Ppard/ Pparg À/À macrophages, increases susceptibility to palmitic acid (PA)-induced cell death, which contributes to the initiation of metabolic inflammation in WAT.
MATERIALS AND METHODS

Animal experiments
2.1.1. Mouse models Stat6 À/À mice and the C57BL/6J controls as well as lysozyme-cre mice were purchased from the Jackson Laboratory (Bar Harbor, ME, USA). Ppard f/f and Pparg f/f in the C57BL/6J background were generated as described previously [23, 24] . Ppard/g f/f mice were obtained by crossing the Ppard f/f and Pparg f/f alleles. These mice were used to create myeloid-specific Ppard À/À , Pparg À/À and Ppard/g À/À mice,
by crossing to lysozyme-cre. All mice were housed in a 12 h light/12 h dark cycle with temperatures of 18e23 C and 40e60% humidity on standard chow diet and allowed food and water ad libitum unless otherwise stated. Mice were sacrificed by CO 2 asphyxiation. All animal studies were approved by the Harvard Medical Area Standing Committee on Animals.
Metabolic studies
In vivo studies were conducted in 3-month-old male mice on normal chow diet (n ¼ 4e7). After 14 h fasting, animals were injected intraperitoneally with 1 mg/kg of CL316,243 (Santa Cruz Biotechnology, Dallas, TX, USA, Cat# sc-203895) or saline and sacrificed 2.5 h after injection.
Stromal vascular fraction (SVF) and ATMs isolation
For SVF isolation, perigonadal adipose tissue was excised and digested with digestion buffer (DMEM, 1 g/L glucose, 2 mg/ml collagenase type II and 2% albumin) at 37 C for 30 min [17] . After filtering through 250 mm nylon mesh, digested adipose tissue was spun down at 400 g for 5 min. The supernatant was discarded and cells were resuspended in washing buffer (DMEM, 1 g/L glucose and 2% albumin Table 1e3 for significantly altered genes). Gene ontology overrepresentation analysis and clustering of significantly altered genes were performed in DAVID (https://david.ncifcrf.gov/) [27, 28] (see Supplementary Tables 4 and 5 for gene lists). Heat maps were generated by MultiExperiment Viewer. Statistical analyses were performed using Student's t test (two tailed). Experiments were conducted with 3e4 replicates and repeated at least three times. In vivo studies were conducted in two cohorts (n ¼ 4e7 per treatment per genotype). Values were presented as means AE SEM. p < 0.05 was considered significant.
Expression analyses and enzymatic assays 2.4.1. Real-time quantitative PCR (qPCR)
Total RNA was isolated from macrophages using PrepEase RNA Spin Kit (Affymetrix, Santa Clara, CA, USA, Cat# 78767) according to manufacturer's protocol. Isolated RNA (1 mg) was reversed transcribed into cDNA using Verso cDNA Synthesis Kit (Thermo Scientific, Cat# AB-1453/B) according to manufacturer's protocol. Quantitative PCR was performed with SYBR green-based assays. 36b4 was used a loading control. Expression of each gene transcript was calculated using a relative standard and normalize to 36b4 [29] . The primers used for qPCR were listed in Supplementary 
Immunoblotting
Protein samples were isolated from BMDMs using RIPA buffer containing protease and phosphatase inhibitors. The extracted proteins were frozen and stored at À80 C. The prepared proteins were subsequently separated by SDS-PAGE and transferred on to membranes. We used PVDF Transfer Membranes (Thermo Scientific, Cat# 88518) for caspase-1 p45 and tubulin, and FluoroTrans Ò PVDF Transfer
Membranes (Pall, Westborough, MA, USA, Cat# BSP0161) for caspase-1 p10. Membranes were incubated in the primary antibodies overnight at 4 C and HRP-conjugated secondary antibodies for 1 h at room temperature. Tubulin was used as loading control. Antibody against caspase-1 was purchased from Santa Cruz Biotechnology (Cat. #SC-514) and tubulin was purchased from Cell Signaling Technology (Danvers, MA, USA, Cat# 2128).
2.4.5. ELISA Supernatants were collected from BMDMs after treatment, and Il-1b concentrations were measured by using Il-1b ELISA kit (BD Biosciences, Cat. #559603) according to manufacturer's protocol.
Mitochondrial respiration
BMDMs were seeded in a 24-well holding plate (Seahorse Bioscience, Billerica, MA, USA). After PA treatment, macrophages were washed 3 times with running medium (DMEM without phenol red supplemented with 5 mM glucose and 1 mM sodium pyruvate pH 7.2e7.4) and subsequently kept in 560 mL running medium in CO 2 37 C incubator for an hour. The basal oxygen consumption rate (OCR) was determined on XF24 Seahorse extracellular flux analyzer (Agilent, Santa Clara, CA, USA). Figure 1A) . In BMDMs from wild-type (WT) mice, GW0742 significantly increased the expression of genes identified by the microarray (e.g., Plin2, Angptl4, and Sgms1; Figure 1C ). These effects were completely abolished in BMDMs from Mac-Ppard/ g À/À but not from Mac-Ppard À/À mice, suggesting that GW0742 at the dose used also activated Pparg and that Pparg shared common target genes with Ppard. In concert, most of the Ppard-controlled genes can also be regulated by Pparg (Supplementary Figure 1B) . Il-4 treated RAW-Ppard cells showed significant induction of cell survival genes [insulin like growth factor 1 (Igf1), B-cell lymphoma 2 (Bcl2) and Sgms1] and M2 markers [histocompatibility 2, class II antigen E beta (H2-Eb1), Mgl1, Ym1 (also called chitinase-like 3, Chil3), and Arginase 1 (Arg1)], and reduced expression of pro-inflammatory genes (Tnf-a and Nlrp3) (Supplementary Figure 1C) . Similar regulation was observed in BMDMs in a Stat6 dependent manner ( Figure 1D ).
Lipotoxicity-induced cell death is exacerbated in
In obesity, increased free FAs released from insulin-resistant adipocytes result in lipotoxicity [8] . Ceramides, derived from FAs can cause cellular dysfunction at elevated concentrations, including cell death and inflammasome activation [12, 13] . Most of genes in the cell death category identified by the array were suppressed by GW501516 or Il-4 treatment (Supplementary Figure 1D and Supplementary Tables 7 and  8 ). 19 of those commonly down-regulated genes in both treatments included many cell death promoters, such as BCL2-like 13 (Bcl2l13) and caspase recruitment domain family, member 9 (Card9). Sgms1 was one of the 6 up-regulated (presumably pro-survival) genes shared by Ppard/g and Stat6 that converts ceramides to sphingomyelin and has been shown to suppress Bcl2-associated X Protein (BAX)-mediated apoptosis and prevent cell death induced by oxidative damage [32, 33] . To determine whether macrophage Ppars and Stat6 play a role in handling lipid-induced toxicity, we challenged BMDMs with PA, one of the most abundant FAs in the body. Flow cytometry assays showed increased annexin-V positive Ppard/g À/À and Stat6 À/À cells after 16 h of PA treatment, compared to control cells (Figure 2A ). There was a two-fold increase in cell death determined by caspase-3 activity in Ppard/g À/À BMDMs, compared to WT cells ( Figure 2B ). Interestingly, deletion of Ppard or Pparg alone in the macrophage was sufficient to promote PA-induced cell death (Supplementary Figure 2) , suggesting that both Ppard and Pparg are required to maintain lipid homeostasis. Stat6 À/À BMDMs also showed significantly increased caspase-3 activity, compared to WT cells ( Figure 2B ). These results demonstrate that macrophages lacking Ppard/g or Stat6 are more susceptible to PA-induced cell death. The Stat6/Ppar transcriptional cascade also regulates macrophage lipid metabolism and mitochondrial function [9, 15] , which could limit lipotoxicity by reducing lipid burden. PA treatment increased mitochondrial respiration determined by OCR in WT BMDMs, and this effect was absent in Ppard/g À/À cells ( Figure 2C ). Although the basal OCR of Stat6 À/À macrophages was higher than that of WT cells as reported previously [16] , PA treatment suppressed, rather than enhanced mitochondrial respiration in Stat6 À/À cells ( Figure 2C ). Similarly, FAinduced b-oxidation was abolished in Ppard/g À/À and Stat6
À/À
BMDMs ( Figure 2D ), while intracellular TG content was elevated in these cells ( Figure 2E) . At the transcriptional level, PA induced expression of Plin2, a welldefined Ppar target gene in lipid droplet formation [34] , was completely abolished in Ppard/g À/À macrophages ( Figure 3A) , consistent with the notion that FAs serve as Ppar agonists. The expression of cell survival genes (Angptl4, Sgms1, Bcl2) was also induced by PA treatment in WT macrophages. This response was blunted in Ppard/g À/À and Stat6 À/À cells ( Figure 3A and B).
We next sought to determine if activation of Ppars or Stat6 could alleviate lipotoxicity-induced cell death. WT BMDMs were primed with GW0742 or Il-4 overnight followed by 16 h of PA treatment. Both GW0742 and Il-4 pretreatment significantly reduced the percentages of annexin-V þ cells ( Figure 3C ). Collectively, these data suggest that the Stat6-Ppard/g axis in the macrophage protects against lipotoxicitytriggered cell death through regulation of genes involved in cell survival, in addition to mitochondrial function and FA metabolism.
Il-4-Stat6 signaling suppresses lipotoxicity-induced inflammasome activation
Lipotoxicity-mediated inflammasome activation has emerged as a key pathogenic contributor to WAT inflammation and its metabolic sequelae [2] . Previous studies suggest PA and its metabolite ceramide can cause NLRP3 inflammasome activation in LPS-primed macrophages [12, 13] . Our microarray results indicated that expression of inflammasome-related genes such as Nlrp3 were inhibited by Il-4 treatment ( Figure 1B) . Furthermore, qPCR in Raw 264.7 cells and BMDMs has demonstrated that Il-4 treatment substantially downregulated Nlrp3 and its downstream effector Il-1b ( Figure 1D and Supplementary Figure 1C) . Based on these observations, we tested if Stat6-Ppar signaling modulates lipotoxicity-induced inflammasome activation. WT, Ppard/g À/À and Stat6 À/À BMDMs were primed with LPS for 3 h followed by 16 h of LPS þ PA treatment. Cell lysates and conditioned media were collected for analysis. Il-1b release in the media determined by ELISA was significantly increased after LPS þ PA stimulation ( Figure 4A ). Ppard/g deficiency resulted in a moderate increase in Il-1b release, while Stat6 disruption led to w10-fold higher Il-1b production ( Figure 4A ). In line with this observation, the level of cleaved caspase-1 (P10) was increased in Stat6 À/À macrophages, and to a lesser extent in Ppard/g À/À macrophages, compared to WT control ( Figure 4B ). Similar results were observed with the level of LDH protein in the media, which serves as a marker for inflammasomeinduced cell death, or pyroptosis ( Figure 4C ). Reciprocally, activating Stat6 in WT BMDMs through Il-4 pretreatment suppressed LPS þ PAinduced Nlrp3 and Il-1b expression, Il-1b production, caspase-1 processing and LDH release (Figure 4DeG ). Ppard/g activation by GW0742 could also suppress inflammasome activation. However, the effect was not as strong as Il-4 treatment (Figure 4DeG ). These findings provide a mechanistic explanation for how M2 activation inhibits metabolic inflammation.
Increased cell death in ATMs from macrophage-specific
Ppard/g À/À or Stat6 À/À mice Results described thus far implicate a critical role of Ppard/Pparg and Stat6 in modulating macrophage survival ex vivo. To validate in vivo functional relevance, mice were fasted for 14 h, followed by injection with a b3-adrenergic agonist CL316,243 to induce lipolysis. The SVF was isolated from perigonadal adipose tissue to assess the ATM phenotype. CL316,243 treatment in fasted mice induced a w2-fold increase in serum free FA levels (Table 1) Figure 3A) . There was no difference in ATM caspase-3 activity between genotypes after 14 h fasting ( Figure 5A , left panel). CL316,243 treatment led to increased caspase-3 activity in Mac-Ppard/g
ATMs, compared to WT cells ( Figure 5A , right panel). ATMs from MacPpard/g À/À mice in both saline and CL316,243 injected groups had reduced expression of FA metabolism, cell survival and M2 genes, while pro-inflammatory genes (e.g., Il-1b and Tnf-a) were upregulated ( Figure 5B and Supplementary Figure 3B) . Consistent with the increased caspase 3 activity, CL316,243 treatment further suppressed survival genes, such as Sgms1 and Bcl2.
On the other hand, fasting-induced lipolysis was sufficient to cause an w60% increase in caspase-3 activity in Stat6 Figure 5D and Supplementary Figure 3D ). In contrast, inflammatory markers, including Il-1b, Nlrp3, and Tnf-a, were up-regulated. CL316,243 treatment similarly exerted a greater effect on decreasing the expression of Sgms1 and Bcl2 in Stat6 À/À ATMs ( Figure 5D ).
Furthermore, concentrations of fasting glucose and insulin were significantly higher in Stat6 À/À than in WT mice after CL316,243 injection (Table 1) . Altogether, these data suggest that an intact Stat6-Ppard/g signaling is required for maintaining ATM homeostasis by protecting macrophages against lipotoxicity-mediated cellular dysfunction.
DISCUSSION
In this study, we describe a mechanism through which M2 polarization protects macrophages from lipotoxicity-mediated cellular dysfunction and consequently maintains adipose tissue homeostasis. Gene expression profiling studies reveal that both Stat6 and Ppar signaling up-regulates pro-survival genes while inhibiting inflammation-related cell death pathways. Along this line, cell death triggered by elevated free FA levels is exacerbated in Ppard/g À/À and Stat6 À/À macrophages both in vitro and in vivo. In addition, Il-4-Stat6 suppresses Nlrp3 inflammasome activation and Il-1b production by PA in LPSprimed macrophages. Whereas M2 macrophages are thought to promote metabolic homeostasis through an anti-inflammatory mechanism, our data indicate that the Th2 cytokine-Stat6-Ppar signaling cascade also increases tolerance to lipid stress within WAT where ATMs encounter fluctuating FA flux. Interestingly, obesity has been shown to increase the viability of pro-inflammatory ATMs mediated by NF-kB [35] , suggesting that selective activation of macrophage survival program through the Stat6-Ppar axis over that of NF-kB is a critical step to limit metabolic inflammation. It has been reported that increased lipolysis either by fasting/badrenergic agonists or obesity promotes macrophage infiltration to WAT [1, 9, 14] . These ATMs accumulate TG-enriched lipid droplets leading to a foamy morphology analogous to cholesterol-laden foam cells in atherosclerosis [9] . In the context of obesity, ATMs are the main source of inflammatory mediators, such as Mcp-1, Tnf-a and Il-1b [1, 9] , implicating a role for FA-mediated metabolic stress in Original Article macrophages, supporting a Stat6-Ppar signaling cascade. Angptl4, a Ppar target, inhibits TG hydrolysis thereby preventing macrophages from lipid overload [37] . This is consistent with a previous report suggesting that ATMs take up excess lipids and secrete anti-lipolytic factors to reduce local free FA concentrations [14] . On the other hand, Stat6 up-regulates Bcl2, a mitochondrial anti-apoptotic gene [38] . The pro-survival effect of Ppars and Stat6 could also be mediated by suppression of cell death promoting genes. Among the cell death/survival genes, Sgms1 is a commonly regulated gene by Ppard/g and Stat6 that reduces levels of ceramide by converting it to sphingomyelin [32, 33] . Ceramide synthesis is elevated by increasing cellular FA uptake [39] and serves as a trigger for cell death and inflammasome activation [1, 13, 15] . This may explain why deletion and activation of Stat6/Ppars enhances and suppresses Nlrp3 inflammasome activation/Il-1b release, respectively. Il-4/Stat6 exhibits a substantially stronger effect likely due to the ability of Stat6 to downregulate Nlrp3 expression. Stat6 À/À macrophages have increased basal mitochondrial oxygen consumption ( Figure 2C ) and, at same time, show more cell death in the fasted state ( Figure 5C ). It is possible that the increased OCR is a compensatory response to defective substrate metabolism (e.g., fat oxidation). In addition, the uncoupled respiration (proton leak) is higher in Figure 3D) that can mediate inflammasome-induced cell death (pyroptosis, Figure 4C ), Stat6 
